The WACC of Brain Scientific Inc (BRSF) is 4.4%.
Range | Selected | |
Cost of equity | 4.7% - 6.6% | 5.65% |
Tax rate | 26.2% - 27.0% | 26.6% |
Cost of debt | 4.0% - 7.0% | 5.5% |
WACC | 3.4% - 5.5% | 4.4% |
Category | Low | High |
Long-term bond rate | 3.9% | 4.4% |
Equity market risk premium | 4.6% | 5.6% |
Adjusted beta | 0.18 | 0.32 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 4.7% | 6.6% |
Tax rate | 26.2% | 27.0% |
Debt/Equity ratio | 2.98 | 2.98 |
Cost of debt | 4.0% | 7.0% |
After-tax WACC | 3.4% | 5.5% |
Selected WACC | 4.4% | |
Debt/Equity | Unlevered | |||
Peers | Company Name | ratio | Beta | beta |
BRSF | Brain Scientific Inc | 2.98 | -0.13 | -0.04 |
APSI | Aqua Power Systems Inc | 0.11 | 0.06 | 0.05 |
BUX.CN | BioMark Diagnostics Inc | 0.02 | -0.26 | -0.26 |
COVE.CN | Cover Technologies Inc | 0.06 | -0.12 | -0.11 |
IZO.CN | Izotropic Corp | 0.14 | -0.59 | -0.54 |
PHCG | Pure Harvest Corporate Group Inc | 8.94 | -0.16 | -0.02 |
RVIV | Reviv3 Procare Co | 0 | 0.07 | 0.07 |
USDR | UAS Drone Corp | 0.06 | -1.03 | -0.99 |
USLG | US Lighting Group Inc | 18.18 | 0.24 | 0.02 |
WIFI.CN | American Aires Inc | 0.04 | 1.21 | 1.17 |
Low | High | |
Unlevered beta | -0.07 | -0.01 |
Relevered beta | -0.22 | -0.01 |
Adjusted relevered beta | 0.18 | 0.32 |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for BRSF:
cost_of_equity (5.65%) = risk_free_rate (4.15%) + equity_risk_premium (5.10%) * adjusted_beta (0.18) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.